A variable domain of heavy chain antibody (VHH) has different binding properties than conventional antibodies. Conventional antibodies prefer binding to the convex portion of the antigen, whereas VHHs prefer epitopes, such as crevices and clefts on the antigen. Therefore, developing candidates with the binding characteristics of camelid VHHs is important. Thus, To this end, a synthetic VHH library that reproduces the structural properties of camelid VHHs was constructed. First, the characteristics of VHHs were classified according to the paratope formation based on crystal structure analyses of the complex structures of VHHs and antigens. Then, we classified 330 complementarity-determining region 3 (CDR3) structures of VHHs from the Protein...
Camel single-domain antibody fragments (VHHs) are promising tools in numerous biotechnological and ...
Monoclonal antibodies have revolutionised the biomedical field through their ubiquitous utilisation ...
Antibodies and antibody-fragments have emerged as promising tools for many therapeutic and biotechno...
International audienceAntigen binding by antibodies requires precise orientation of the complementar...
We have constructed a human VH library based on a camelized VH sequence. The library was constructed...
Camelids produce functional antibodies devoid of light chains. Autono-mous heavy chain variable (VHH...
Antibodies and antibody fragments are essential tools in basic research, diagnostics and therapy. Co...
Abstract Objective To determine the X-ray structure and biophysical properties of a Camelid VHH isol...
We have constructed a human V(H) library based on a camelized V(H) sequence. The library was constru...
International audienceThe VHHs are antigen-binding region/domain of camelid heavy chain antibodies (...
All camelids and dromedaries in particular have unique antibodies circulating in their blood. Unlike...
AbstractAmong mammals, camelids have a unique immunological system since they produce functional ant...
A structure-based approach was used to design libraries of synthetic heavy chain complementarity det...
The antibody V(H) domains of camelids tend to be soluble and to resist aggregation, in contrast to h...
International audienceVHH stands for the variable regions of heavy chain only of camelid IgGs. The V...
Camel single-domain antibody fragments (VHHs) are promising tools in numerous biotechnological and ...
Monoclonal antibodies have revolutionised the biomedical field through their ubiquitous utilisation ...
Antibodies and antibody-fragments have emerged as promising tools for many therapeutic and biotechno...
International audienceAntigen binding by antibodies requires precise orientation of the complementar...
We have constructed a human VH library based on a camelized VH sequence. The library was constructed...
Camelids produce functional antibodies devoid of light chains. Autono-mous heavy chain variable (VHH...
Antibodies and antibody fragments are essential tools in basic research, diagnostics and therapy. Co...
Abstract Objective To determine the X-ray structure and biophysical properties of a Camelid VHH isol...
We have constructed a human V(H) library based on a camelized V(H) sequence. The library was constru...
International audienceThe VHHs are antigen-binding region/domain of camelid heavy chain antibodies (...
All camelids and dromedaries in particular have unique antibodies circulating in their blood. Unlike...
AbstractAmong mammals, camelids have a unique immunological system since they produce functional ant...
A structure-based approach was used to design libraries of synthetic heavy chain complementarity det...
The antibody V(H) domains of camelids tend to be soluble and to resist aggregation, in contrast to h...
International audienceVHH stands for the variable regions of heavy chain only of camelid IgGs. The V...
Camel single-domain antibody fragments (VHHs) are promising tools in numerous biotechnological and ...
Monoclonal antibodies have revolutionised the biomedical field through their ubiquitous utilisation ...
Antibodies and antibody-fragments have emerged as promising tools for many therapeutic and biotechno...